These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 28965335)

  • 1. Pregabalin Use Among Users of Illicit Drugs: A Cross-Sectional Survey in Southern Germany.
    Snellgrove BJ; Steinert T; Jaeger S
    CNS Drugs; 2017 Oct; 31(10):891-898. PubMed ID: 28965335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of use, abuse and dependence on legal and illegal psychotropic substances in an adolescent inpatient psychiatric population.
    Niethammer O; Frank R
    Eur Child Adolesc Psychiatry; 2007 Jun; 16(4):254-9. PubMed ID: 17171573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pregabalin misuse in methadone maintenance treatment patients in Israel: Prevalence and risk factors.
    Sason A; Adelson M; Schreiber S; Peles E
    Drug Alcohol Depend; 2018 Aug; 189():8-11. PubMed ID: 29857329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [On the risk of dependence on gabapentinoids].
    Bonnet U; Scherbaum N
    Fortschr Neurol Psychiatr; 2018 Feb; 86(2):82-105. PubMed ID: 29179227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of use, abuse and dependence of illicit drugs among adolescents and young adults in a community sample.
    Perkonigg A; Lieb R; Wittchen HU
    Eur Addict Res; 1998 Mar; 4(1-2):58-66. PubMed ID: 9740818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patterns of Pregabalin Users from Substance Abuse Treatment Facilities: Results from the French OPPIDUM Program from 2008 to 2022.
    Garnier C; Schein M; Lacroix C; Jouve E; Soeiro T; Gentile G; Lapeyre Mestre M; Micallef J
    CNS Drugs; 2024 Sep; 38(9):743-751. PubMed ID: 38990472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Psychoactive drug use in a declared non-addicted control sample and comorbidity. Results of a study in 860 French-speaking subjects].
    Nezelof S; Taccoen Y; Corcos M; Girardon N; Perez-Diaz F; Bizouard P; Venisse JL; Halfon O; Loas G; Lang F; Flament M; Jeammet P
    Ann Med Interne (Paris); 2001 Apr; 152 Suppl 3():IS18-25. PubMed ID: 11435991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychoactive drug abuse in older adults.
    Simoni-Wastila L; Yang HK
    Am J Geriatr Pharmacother; 2006 Dec; 4(4):380-94. PubMed ID: 17296542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pregabalin can cause addiction and withdrawal symptoms].
    Nordgaard J; Jürgens G
    Ugeskr Laeger; 2015 Jan; 177(2A):38-9. PubMed ID: 25612958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of substance use and psychiatric disorders in a highly select chronic pain population.
    Proctor SL; Estroff TW; Empting LD; Shearer-Williams S; Hoffmann NG
    J Addict Med; 2013; 7(1):17-24. PubMed ID: 23131838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychometric properties of DSM assessments of illicit drug abuse and dependence: results from the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC).
    Lynskey MT; Agrawal A
    Psychol Med; 2007 Sep; 37(9):1345-55. PubMed ID: 17407621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pregabalin for the treatment of patients with generalized anxiety disorder with inadequate treatment response to antidepressants and severe depressive symptoms.
    Olivares JM; Álvarez E; Carrasco JL; Pérez Páramo M; López-Gómez V
    Int Clin Psychopharmacol; 2015 Sep; 30(5):265-71. PubMed ID: 26111356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anabolic ergogenic substance users in fitness-sports: a distinct group supported by the health care system.
    Striegel H; Simon P; Frisch S; Roecker K; Dietz K; Dickhuth HH; Ulrich R
    Drug Alcohol Depend; 2006 Jan; 81(1):11-9. PubMed ID: 16009506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparative study of substance dependence comorbidity in bipolar, schizophrenic and schizoaffective disorders].
    Verdoux H; Mury M; Besançon G; Bourgeois M
    Encephale; 1996; 22(2):95-101. PubMed ID: 8706627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Consulting for substance abuse: mental disorders among adolescents and their parents.
    Hodgins S; Tengström A; Bylin S; Göranson M; Hagen L; Janson M; Larsson A; Lundgren-Andersson C; Lundmark C; Norell E; Pedersen H
    Nord J Psychiatry; 2007; 61(5):379-86. PubMed ID: 17990200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Acting out and psychoactive substances: alcohol, drugs, illicit substances].
    Gillet C; Polard E; Mauduit N; Allain H
    Encephale; 2001; 27(4):351-9. PubMed ID: 11686057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral health status of a group of illicit drug users in Delhi, India.
    Gupta T; Shah N; Mathur VP; Dhawan A
    Community Dent Health; 2012 Mar; 29(1):49-54. PubMed ID: 22482250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of Lifetime Mental Disorders and Subsequent Alcohol and Illicit Drug Use: Results From the National Comorbidity Survey-Adolescent Supplement.
    Conway KP; Swendsen J; Husky MM; He JP; Merikangas KR
    J Am Acad Child Adolesc Psychiatry; 2016 Apr; 55(4):280-8. PubMed ID: 27015718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patterns of drug abuse among drug users with regular and irregular attendance for treatment as detected by comprehensive UHPLC-HR-TOF-MS.
    Sundström M; Pelander A; Simojoki K; Ojanperä I
    Drug Test Anal; 2016 Jan; 8(1):39-45. PubMed ID: 26017246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of illicit drugs by truck drivers arriving at Paranaguá port terminal, Brazil.
    Peixe TS; de Almeida RM; Girotto E; de Andrade SM; Mesas AE
    Traffic Inj Prev; 2014; 15(7):673-7. PubMed ID: 24313348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.